A detailed history of National Asset Management, Inc. transactions in Ardelyx, Inc. stock. As of the latest transaction made, National Asset Management, Inc. holds 90,000 shares of ARDX stock, worth $432,000. This represents 0.02% of its overall portfolio holdings.

Number of Shares
90,000
Previous 87,000 3.45%
Holding current value
$432,000
Previous $644,000 3.73%
% of portfolio
0.02%
Previous 0.02%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Dec 13, 2024

BUY
$5.28 - $7.57 $15,840 - $22,710
3,000 Added 3.45%
90,000 $620,000
Q2 2024

Aug 19, 2024

BUY
$5.89 - $9.31 $512,430 - $809,970
87,000 New
87,000 $644,000

Others Institutions Holding ARDX

About ARDELYX, INC.


  • Ticker ARDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 154,636,000
  • Market Cap $742M
  • Description
  • Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel synd...
More about ARDX
Track This Portfolio

Track National Asset Management, Inc. Portfolio

Follow National Asset Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of National Asset Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on National Asset Management, Inc. with notifications on news.